from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1346/mbtN

LFCtreatmentdescriptionclass of inhibitor

-0.129

Amikacinug/mL Amikacintranslation

-0.757

Cap5-10ug/mL Capreomycintranslation

-0.924

Rox10-50 ug/mL Roxithromycintranslation

-1.230

SM2-5 ug/mL Streptomycintranslation

0.119

Tet5-10 ug/mL Tetracyclinetranslation

1.307

Rif0.2-5ug/mL Rifampicintranscription

-0.106

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.370

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.645

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.247

CPZ10-50 ug/mL Chlorpromazinerespiration

4.576

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.191

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.014

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.282

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.566

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.200

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.200

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.171

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.286

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.991

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.164

KCN5-20 ug/mL Potassium cyaniderespiration

0.133

NaN30.2-2 mM Sodium aziderespiration

-0.794

Nigericin50 uM Nigericinrespiration

0.385

TRC10-150 ug/mL Triclosanrespiration

0.569

TRZ10-25 ug/mL Thioridazinerespiration

-0.078

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.696

menadione6-10 ug/mL Menadionerespiration

1.755

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.151

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.630

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.197

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.116

NRP_1Non-replicating persistence stage 1dosRassociated

-0.949

Amp0.2mg/mL AmpicillincellWall

-0.401

Cephalexin20-100 ug/mL CephalexincellWall

-0.225

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.071

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.014

EMB10-20 ug/mL EthambutolcellWall

-0.293

Eta12-40 ug/mL EthionamidecellWall

-0.017

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.144

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.835

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.092

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.053

BZA0.12 mg/mL BenzamidearomaticAmides

-0.045

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.265

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.504

H2O24 mM hydrogen peroxideDNAdamaging

-0.277

Levo10 ug/mL LevofloxacinDNAdamaging

-0.305

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.434

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.477

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.669

UVUV-irradiationDNAdamaging

1.283

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.321

Antimycin12.5-50 ug/mL Antimycin A?

-1.006

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.135

PA_110-50 ug/mL Antitubercular compound PA-1?

0.066

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.318

PA8240.2-2 ug/mL PA-824?

0.185

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.068

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.093

Verapamil50 uM Verapamil?

-0.588

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.547

methoxatin10-20 ug/mL Methoxatin?